These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4441194)

  • 21. An investigation into the bradycardic effects of ST 155 [2-(2,6-dichlorophenylamino)-2-imidazoline HCl] in the anesthetized dog.
    Robson RD; Kaplan HR; Laforce S
    J Pharmacol Exp Ther; 1969 Sep; 169(1):120-31. PubMed ID: 4389918
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.
    Thoenen H; Huerlimann A; Haefely W
    J Pharmacol Exp Ther; 1966 Feb; 151(2):189-95. PubMed ID: 5932597
    [No Abstract]   [Full Text] [Related]  

  • 23. Demonstration of central sympathetic excitation and inhibition on the nictitating membrane of the cat.
    Molnár J; György L; Unyi G
    Acta Physiol Acad Sci Hung; 1969; 36(1):137-55. PubMed ID: 5378639
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacology of Go-1002.
    Grewal RS; Kaul CL; David J
    J Pharmacol Exp Ther; 1968 Apr; 160(2):268-76. PubMed ID: 4384786
    [No Abstract]   [Full Text] [Related]  

  • 25. The pharmacological effects of an unusual hypotensive agent: (SK & F 11197, 2,6-diamino-4-dimethylamino-ethoxy pyrimidine). I. Effects on the cardiovascular system.
    Ehrreich SJ; Heringslake JE; Warren FR; Weinstock J; Tedeschi RE
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):284-302. PubMed ID: 5367304
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of methyldopa, reserpine and guanethidine on hindleg vascular resistance.
    Mohammed S; Gaffney TE; Yard AC; Gomez H
    J Pharmacol Exp Ther; 1968 Apr; 160(2):300-7. PubMed ID: 5651373
    [No Abstract]   [Full Text] [Related]  

  • 27. On the adrenergic neuron blocking activity of 1-methyl-3-keto-4-phenylquinuclidinium bromide (MA540) during acute and chronic administration.
    Hong E
    Arzneimittelforschung; 1976; 26(9):1657-62. PubMed ID: 1036694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation.
    Raval P; Bingham S; Aiyar N; Elliott JD; Hunter AJ; Ohlstein EH; Parsons AA
    Br J Pharmacol; 1999 Jan; 126(2):485-93. PubMed ID: 10077242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of some actions of guanethidine by the acute administration of reserpine.
    Guimarães S; Sottomayor M; Castro-Tavares J
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(2):119-30. PubMed ID: 4245718
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clonidine modification of the cardiac effects of vagal stimulation in dogs].
    Duchêne-Maruliaz P; Combre A; Lapalus P; Boucher M; Lavarenne J
    C R Seances Soc Biol Fil; 1971; 165(2):296-8. PubMed ID: 4258403
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular effects of losulazine hydrochloride, a peripheral norepinephrine-depleting agent, in nonhuman primates.
    Pals DT; DeGraaf GL
    J Pharmacol Exp Ther; 1985 Feb; 232(2):407-12. PubMed ID: 3968642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective effects of clonidine on the canine sinus node.
    Primm RK; Urthaler F; James TN
    J Pharmacol Exp Ther; 1980 Jul; 214(1):223-8. PubMed ID: 6104717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (Tolonidine), a new antihypertensive agent. I. Action on blood pressure and heart rate.
    Cosnier D; Duchene-Marullaz P; Grimal J; Rispat G; Streichenberger G
    Arzneimittelforschung; 1975 Oct; 25(10):1557-61. PubMed ID: 1243037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cardiovascular effects of the antihypertensive drug debrisoquin: a contribution to the pharmacology of chronic treatment. I. One-week administration to dogs.
    Cavero I; Gerold M; Saner A; Haeusler G
    J Pharmacol Exp Ther; 1978 Jul; 206(1):123-31. PubMed ID: 660542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of sympathetic stimulation and vasoactive substances on the canine pulmonary veins.
    Kadowitz PJ; Joiner PD; Hyman AL
    J Clin Invest; 1975 Aug; 56(2):354-65. PubMed ID: 1150876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ST 155-induced cardiac slowing in dogs.
    Kaplan HR; La Sala SA; Simon A; Robson RD
    Eur J Pharmacol; 1969 May; 6(2):193-6. PubMed ID: 5796805
    [No Abstract]   [Full Text] [Related]  

  • 39. The cardiovascular effects of two new triazine antimalarials, BRL 50216 (Clociguanil) and BRL 6231.
    Nettleton MJ; Poyser RH; Shorter JH
    Toxicol Appl Pharmacol; 1974 Feb; 27(2):271-82. PubMed ID: 4854671
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanism of hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155) in the cat.
    Magus RD; Long JP
    J Pharm Sci; 1968 Apr; 57(4):594-8. PubMed ID: 5652149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.